205 related articles for article (PubMed ID: 10037249)
1. Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities.
Matsuoka H; Fors H; Bosaeus I; Rosberg S; Albertsson-Wikland K; Bjarnason R
Eur J Endocrinol; 1999 Jan; 140(1):35-42. PubMed ID: 10037249
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin levels correlate with growth hormone secretion and body fat in children.
Fors H; Matsuoka H; Bosaeus I; Rosberg S; Wikland KA; Bjarnason R
J Clin Endocrinol Metab; 1999 Oct; 84(10):3586-90. PubMed ID: 10523000
[TBL] [Abstract][Full Text] [Related]
3. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
[TBL] [Abstract][Full Text] [Related]
4. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
5. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
6. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
7. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
8. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
9. Fat distribution in short-stature children born small for gestational age.
Maeyama T; Ida S; Onuma S; Shoji Y; Yamamoto T; Etani Y; Kawai M
Pediatr Int; 2020 Dec; 62(12):1351-1356. PubMed ID: 32521070
[TBL] [Abstract][Full Text] [Related]
10. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
Schweizer R; Martin DD; Schönau E; Ranke MB
J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
[TBL] [Abstract][Full Text] [Related]
11. Body composition, fasting leptin, and sex steroid administration determine GH sensitivity in peripubertal short children.
Coutant R; Boux de Casson F; Rouleau S; Douay O; Mathieu E; Audran M; Limal JM
J Clin Endocrinol Metab; 2001 Dec; 86(12):5805-12. PubMed ID: 11739442
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone therapy in children with idiopathic short stature - the effect on appetite and appetite-regulating hormones: a pilot study.
Yackobovitch-Gavan M; Gat-Yablonski G; Shtaif B; Hadani S; Abargil S; Phillip M; Lazar L
Endocr Res; 2019; 44(1-2):16-26. PubMed ID: 29979896
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
[TBL] [Abstract][Full Text] [Related]
14. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
Rogol AD; Blethen SL; Sy JP; Veldhuis JD
Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
[TBL] [Abstract][Full Text] [Related]
15. Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects.
Gill MS; Toogood AA; O'Neill PA; Adams JE; Thorner MO; Shalet SM; Clayton PE
Clin Endocrinol (Oxf); 1997 Aug; 47(2):161-7. PubMed ID: 9302388
[TBL] [Abstract][Full Text] [Related]
16. Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency.
Florkowski CM; Collier GR; Zimmet PZ; Livesey JH; Espiner EA; Donald RA
Clin Endocrinol (Oxf); 1996 Dec; 45(6):769-73. PubMed ID: 9039344
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in the growth hormone-releasing hormone (GHRH) receptor.
de A Barretto ES; Gill MS; De Freitas ME; Magalhães MM; Souza AH; Aguiar-Oliveira MH; Clayton PE
Clin Endocrinol (Oxf); 1999 Nov; 51(5):559-64. PubMed ID: 10594516
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH.
Kamp GA; Zwinderman AH; Van Doorn J; Hackeng W; Frölich M; Schönau E; Wit JM
Clin Endocrinol (Oxf); 2002 Sep; 57(3):315-25. PubMed ID: 12201823
[TBL] [Abstract][Full Text] [Related]
20. Variation of bone acquisition during growth hormone treatment in children can be explained by proteomic biomarkers, bone formation markers, body composition and nutritional factors.
Swolin-Eide D; Andersson B; Hellgren G; Magnusson P; Albertsson-Wikland K
Bone; 2018 Nov; 116():144-153. PubMed ID: 30071306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
